More Immutep Ltd news Immutep LtdASX: IMM 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial May 25, 2023 at 2:39 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
